NOVEL DOXORUBICIN ANALOGS: CARDIAC AND CYTOTOXIC EFFECTS

Information

• Research Project
• 6134192

• ApplicationId

  6134192

• Core Project Number

  R41HL064986

• Full Project Number

  1R41HL064986-01

• Serial Number

  64986

• FOA Number

• Sub Project Id

• Project Start Date

  5/15/2000 - 24 years ago

• Project End Date

  5/14/2001 - 23 years ago

• Program Officer Name

  WOLPERT, MARY K

• Budget Start Date

  5/15/2000 - 24 years ago

• Budget End Date

  5/14/2001 - 23 years ago

• Fiscal Year

  2000

• Support Year

  1

• Suffix

• Award Notice Date

  5/12/2000 - 24 years ago

Organizations

• Gem Pharmaceuticals, LLC

IC Name

• Activity

  R41

• Administering IC

  HL

• Application Type

  1

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  134283

• Sub Project Total Cost

• ARRA Funded

• CFDA Code

  837

• Ed Inst. Type

• Funding ICs

  NHLBI:134283\

• Funding Mechanism

• Study Section

  ZRG1

• Study Section Name

  Special Emphasis Panel

• Organization Name

  GEM PHARMACEUTICALS, LLC

• Organization Department

• Organization DUNS

• Organization City

  BIRMINGHAM

• Organization State

  AL

• Organization Country

  UNITED STATES

• Organization Zip Code

  35244

• Organization District

  UNITED STATES